Document is current

Any future updates will be listed below

Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

Crossref DOI link: https://doi.org/10.1007/s12325-025-03244-1

Published Online: 2025-07-11

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark